Chargement en cours...
Angiotensin Receptor‐Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension
BACKGROUND: Pulmonary hypertension (PH) results in increased right ventricular (RV) afterload and ventricular remodeling. Sacubitril/valsartan (sac/val) is a dual acting drug, composed of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan, that has shown promising out...
Enregistré dans:
| Publié dans: | J Am Heart Assoc |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7670537/ https://ncbi.nlm.nih.gov/pubmed/32552157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015708 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|